Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies

Molecular Therapy(2024)10.1016/j.ymthe.2024.04.019Source: DataRank Database

mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies is a research paper published in Molecular Therapy (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 3.23)OA: hybridTopics (47)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Carolina R. Melo‐Silva ORCID,Lingjuan Tang ORCID,Samita Kafle ORCID,Peter Lidskiy,Csaba Bajusz

Live enrichment

PubMed:38605519 PMC:PMC11184341 OpenAlex:https://openalex.org/W4394765734

Hungarian Academy of Sciences

Grant: LP2017-7/2017

NIAID

Grant: T32AI134646

NIAID NIH HHS

Grant: R01 AI175567

NIAID NIH HHS

Grant: P01 AI158571

NIAID NIH HHS

Grant: R01 AI146101

NIAID NIH HHS

Grant: R01 AI169460

NIAID NIH HHS

Grant: R56 AI110457

NIAID NIH HHS

Grant: R01 AI153064

NIGMS NIH HHS

Grant: T32 GM144302

Pfizer

Gilead Sciences

Thomas Jefferson University

National Institutes of Health

FWCI

3.23

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ymthe.2024.04.019

publisherhttps://doi.org/10.1016/j.ymthe.2024.04.019

publisherhttps://api.elsevier.com/content/article/PII:S1525001624002363?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001624002363?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38605519

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19AnimalsCD8-Positive T-LymphocytesMiceSARS-CoV-2COVID-19FemaleSpike Glycoprotein, CoronavirusCOVID-19 VaccinesMaleAntibodies, ViralMice, Inbred C57BLHumansDisease Models, Animal

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAnimalsAntibodies, ViralDisease Models, AnimalFemaleHumansMaleMice, Inbred C57BLCD8-Positive T-LymphocytesMiceSpike Glycoprotein, Coronavirus

Keywords

VirologyAntibodyBiologyCD8Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakImmunologyImmune systemMedicineOutbreakInfectious disease (medical specialty)DiseaseAntibodiesMiceCd8 T cellsSars-cov-2Mrna-lnp Vaccines

Sustainable Development Goals

SDG 0: Good health and well-being